Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir Alafenamide vs Tenofovir DF in HIV-1
NCT00036634Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2002
- Primary completion
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences. Started Mar 2002; status: completed.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00036634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036634.